Company profile
UK company 06605196, incorporated on 29 May 2008.
Home | Avacta Life Sciences Limited
We develop safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer and pre|CISION platforms
Company number 06605196
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Nov 2015 to 31 May 2018
To validate multiplexed tests using Affimer technology for early detection of bacterial infections and sepsis
1 Jun 2014 to 31 Aug 2016
Promexus is a new biotechnology company which will be developing a novel human therapeutic protein (the Affimer) that will address some of the shortcomings of the current antibody based drugs. Antibodies have been very successful at treating a wide range of human disease such as asthma, arthritis and cancer, but they are expensive to produce and because o...
